JP2023536511A5 - - Google Patents

Info

Publication number
JP2023536511A5
JP2023536511A5 JP2023508090A JP2023508090A JP2023536511A5 JP 2023536511 A5 JP2023536511 A5 JP 2023536511A5 JP 2023508090 A JP2023508090 A JP 2023508090A JP 2023508090 A JP2023508090 A JP 2023508090A JP 2023536511 A5 JP2023536511 A5 JP 2023536511A5
Authority
JP
Japan
Prior art keywords
pain
substituted
compound
salt
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023508090A
Other languages
English (en)
Japanese (ja)
Other versions
JP7802256B2 (ja
JP2023536511A (ja
Filing date
Publication date
Priority claimed from EP20189671.9A external-priority patent/EP3950683A1/en
Priority claimed from EP20197363.3A external-priority patent/EP3971179A1/en
Priority claimed from EP20204664.5A external-priority patent/EP3992188A1/en
Priority claimed from PCT/EP2021/071755 external-priority patent/WO2022029170A1/en
Application filed filed Critical
Publication of JP2023536511A publication Critical patent/JP2023536511A/ja
Publication of JP2023536511A5 publication Critical patent/JP2023536511A5/ja
Priority to JP2025130545A priority Critical patent/JP2025168356A/ja
Priority to JP2025130544A priority patent/JP2025168355A/ja
Publication of JP7802256B2 publication Critical patent/JP7802256B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023508090A 2020-08-05 2021-08-04 ジフルオロメチル-ピリジン-2-イルトリアゾール Active JP7802256B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025130544A JP2025168355A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール
JP2025130545A JP2025168356A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP20189671.9A EP3950683A1 (en) 2020-08-05 2020-08-05 Difluoromethyl-pyridin-2-yl triazoles
EP20189671.9 2020-08-05
EP20197363.3 2020-09-22
EP20197363.3A EP3971179A1 (en) 2020-09-22 2020-09-22 Difluoromethyl-pyridin-2-yl triazoles
EP20204664.5A EP3992188A1 (en) 2020-10-29 2020-10-29 Difluoromethyl-pyridin-2-yl triazoles
EP20204664.5 2020-10-29
PCT/EP2021/071755 WO2022029170A1 (en) 2020-08-05 2021-08-04 Difluoromethyl-pyridin-2-yl triazoles

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2025130545A Division JP2025168356A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール
JP2025130544A Division JP2025168355A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール

Publications (3)

Publication Number Publication Date
JP2023536511A JP2023536511A (ja) 2023-08-25
JP2023536511A5 true JP2023536511A5 (https=) 2024-08-08
JP7802256B2 JP7802256B2 (ja) 2026-01-20

Family

ID=77447863

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2023508090A Active JP7802256B2 (ja) 2020-08-05 2021-08-04 ジフルオロメチル-ピリジン-2-イルトリアゾール
JP2025130544A Pending JP2025168355A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール
JP2025130545A Pending JP2025168356A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025130544A Pending JP2025168355A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール
JP2025130545A Pending JP2025168356A (ja) 2020-08-05 2025-08-05 ジフルオロメチル-ピリジン-2-イルトリアゾール

Country Status (7)

Country Link
US (1) US20230286946A1 (https=)
EP (3) EP4596558A3 (https=)
JP (3) JP7802256B2 (https=)
CN (3) CN116888115B (https=)
ES (1) ES3061465T3 (https=)
PL (1) PL4192823T3 (https=)
WO (1) WO2022029170A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240425491A1 (en) 2021-05-05 2024-12-26 University College Cardiff Consultants Limited Heteroaryl compounds useful in the treatment of cognitive disorders
AU2022327398A1 (en) * 2021-08-12 2024-03-21 Shanghai SIMR Biotechnology Co., Ltd Substituted triazole derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof
EP4514348A4 (en) * 2022-04-29 2025-12-31 Noetix Pharma Llc PREVENTION AND TREATMENT OF POSTOPERATIVE COGNITIVE DYSFUNCTIONS (POCD)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8742097B2 (en) * 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
CA2876778A1 (en) * 2012-06-26 2014-01-03 Saniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
US9475797B2 (en) * 2012-06-26 2016-10-25 Saniona A/S Phenyl triazole derivative and its use for modulating the GABAA receptor complex
WO2014001279A1 (en) * 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
TWI752155B (zh) * 2017-02-01 2022-01-11 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
MA53158A (fr) 2018-07-20 2021-05-26 Aicuris Gmbh & Co Kg Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis

Similar Documents

Publication Publication Date Title
JP2023536511A5 (https=)
RU2470011C2 (ru) Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
IL295371A (en) Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders
JP2013526615A5 (https=)
JP4740115B2 (ja) 置換ピラゾール
EP1339716A1 (de) Neue lactam-substituierte pyrazolopyridinderivate
AU2002237654B2 (en) Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
JP6968899B2 (ja) 向精神薬およびその使用
KR100761562B1 (ko) 부신피질 자극 호르몬 방출 인자 길항제로서의 인다졸 유도체
KR20140006768A (ko) Lsd1의 아릴사이클로프로필아민 기반 디메틸라아제 억제제 및 이의 의학적 이용
NZ285442A (en) Corticotropin-releasing factor antagonists comprising pyridines, pyrimidines, purinoses, pyrrolopyrimidinones and pyrrolopyridinone compounds
JP2014114312A (ja) イソオキサゾール誘導体及び代謝型グルタミン酸受容体ポテンシエーターとしてのその使用
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
CN110366555A (zh) 甾族类衍生物调节剂、其制备方法和应用
US20110003862A1 (en) 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases
IE911859A1 (en) Pharmacologically active cns compounds
EP1682549B1 (en) Imidazo[1,2-a]pyridine anxiolytics
JP2006528957A (ja) 改善された抗精神病効力を有するインドール誘導体
AU2021262281A1 (en) 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof
JP2009516676A (ja) 置換二環式ピリミドン誘導体
WO2021000785A1 (zh) 作为詹纳斯激酶1选择抑制剂的吡咯并[2,3-b]吡啶衍生物
JP2014501772A (ja) タンパク質チロシンキナーゼ阻害薬としての新規スルファミドピペラジン誘導体およびその医薬用途
US11377421B2 (en) Psychotropic agents and uses thereof
JP2006525281A (ja) ピリジニルアセトニトリル類
CN113248491A (zh) 一类取代的吲哚脲衍生物、合成方法及其用途